Literature DB >> 8467548

Comparison of the direct effects of sevoflurane, isoflurane and halothane on isolated canine coronary arteries.

K Nakamura1, H Toda, Y Hatano, K Mori.   

Abstract

We have demonstrated previously, using dog epicardial arteries of different sizes, that isoflurane, like adenosine, is preferentially a small coronary artery dilator, whereas halothane, like nitroglycerin, is a large artery dilator. The present study was designed to compare the direct effects of sevoflurane with those of isoflurane and halothane. Proximal large coronary arteries with an outer diameter (o.d.) of 2.5-3.2 mm and distal small arteries of 0.6-0.9 mm o.d. were isolated from dogs and then cut into vascular rings. They were precontracted with KCl (20 mM), and their relaxant responses to anaesthetics were compared relative to the maximal responses induced by papaverine. Sevoflurane, halothane and isoflurane (1-3 human MAC) induced dose-dependent relaxation of these arteries. The relaxant response to sevoflurane did not differ between large and small arteries. However, the relaxant response of the large arteries to halothane (1.5-2.3%) was greater than that of small arteries (P < 0.01) and the response of small arteries to isoflurane (3.5%) was greater than that of large arteries (P < 0.05). In large arteries, the potency of the relaxant effect at equivalent human MAC could be ranked as halothane > or = sevoflurane > isoflurane, and, in small epicardial arteries as isoflurane > sevoflurane >> halothane. We conclude that, unlike isoflurane, sevoflurane is not a preferential dilator of small coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467548     DOI: 10.1007/BF03037038

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  20 in total

1.  Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages.

Authors:  W C Stevens; W M Dolan; R T Gibbons; A White; E I Eger; R D Miller; R H DeJong; R M Elashoff
Journal:  Anesthesiology       Date:  1975-02       Impact factor: 7.892

2.  Effect of nitroglycerin and dipyridamole on regional coronary resistance.

Authors:  W M Fam; M McGregor
Journal:  Circ Res       Date:  1968-05       Impact factor: 17.367

3.  Coronary steal in four models of single or multiple vessel obstruction in dogs.

Authors:  G J Gross; D C Warltier
Journal:  Am J Cardiol       Date:  1981-07       Impact factor: 2.778

4.  Response of large and small coronary arteries to nitroglycerin, NaNO 2 , and adenosine.

Authors:  R L Schnaar; H V Sparks
Journal:  Am J Physiol       Date:  1972-07

5.  Haemodynamic and organ blood flow responses to sevoflurane during spontaneous ventilation in the rat: a dose-response study.

Authors:  M W Crawford; J Lerman; M Pilato; H Orrego; V Saldivia; F J Carmichael
Journal:  Can J Anaesth       Date:  1992-03       Impact factor: 5.063

6.  Minimum alveolar concentrations of methoxyflurane, halothane, ether and cyclopropane in man: correlation with theories of anesthesia.

Authors:  L J Saidman; E I Eger; E S Munson; A A Babad; M Muallem
Journal:  Anesthesiology       Date:  1967 Nov-Dec       Impact factor: 7.892

7.  Porcine systemic and regional organ blood flow during 1.0 and 1.5 minimum alveolar concentrations of sevoflurane anesthesia without and with 50% nitrous oxide.

Authors:  M Manohar; C M Parks
Journal:  J Pharmacol Exp Ther       Date:  1984-12       Impact factor: 4.030

8.  Systemic and regional hemodynamics of isoflurane and sevoflurane in rats.

Authors:  P F Conzen; B Vollmar; H Habazettl; E J Frink; K Peter; K Messmer
Journal:  Anesth Analg       Date:  1992-01       Impact factor: 5.108

9.  Differential effects of isoflurane on regional right and left ventricular performances, and on coronary, systemic, and pulmonary hemodynamics in the dog.

Authors:  H J Priebe
Journal:  Anesthesiology       Date:  1987-03       Impact factor: 7.892

10.  Isoflurane induces coronary steal in a canine model of chronic coronary occlusion.

Authors:  C W Buffington; J L Romson; A Levine; N C Duttlinger; A H Huang
Journal:  Anesthesiology       Date:  1987-03       Impact factor: 7.892

View more
  5 in total

1.  Comparison of sevoflurane/fentanyl and isoflurane/fentanyl during elective coronary artery bypass surgery. Sevoflurane Venture Group.

Authors:  N R Searle; R J Martineau; P Conzen; A al-Hasani; L Mark; T Ebert; M Muzi; L R Hodgins
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

2.  Differential vascular reactivity of canine mesenteric arteries and veins to sevoflurane.

Authors:  Kazu-Ichi Yoshida; Akiyoshi Ohsawa
Journal:  J Anesth       Date:  1998-03       Impact factor: 2.078

Review 3.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

4.  Sevoflurane inhibits angiotensin II-induced Rho kinase-mediated contraction of vascular smooth muscle from spontaneously hypertensive rat.

Authors:  Nobuhiko Uematsu; Koji Ogawa; Yasuyuki Tokinaga; Kazuaki Tange; Yoshio Hatano
Journal:  J Anesth       Date:  2011-03-16       Impact factor: 2.078

5.  Mechanisms of inhibition of endothelium-dependent relaxation by halothane, isoflurane, and sevoflurane.

Authors:  K Nakamura; K Terasako; H Toda; I Miyawaki; M Kakuyama; M Nishiwada; Y Hatano; K Mori
Journal:  Can J Anaesth       Date:  1994-04       Impact factor: 5.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.